CeriBell Inc
CBLL11.385USD
+0.065+0.57%
Close 10/31, 16:00（ET）Quotes delayed by 15 min
416.69MMarket Cap
LossP/E TTM
More Details of CeriBell Inc Company
Ceribell, Inc. is a commercial-stage medical technology company. It is focused on transforming the diagnosis and management of patients with serious neurological conditions. It has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies. Its Clarity AI algorithm interprets EEG in real-time, provides bedside alerts and continuous monitoring for status epilepticus. The Ceribell EEG Portal makes it easy to remotely review EEG in real-time with pre-annotated EEG insights.
CeriBell Inc Info
Ticker SymbolCBLL
Company nameCeribell Inc
IPO dateOct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Number of employees281
Security typeOrdinary Share
Fiscal year-endOct 11
Address360 N. Pastoria Avenue
CitySUNNYVALE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94085
Phone18004360826
Websitehttps://ceribell.com/
Ticker SymbolCBLL
IPO dateOct 11, 2024
CEOMs. Xingjuan (Jane) Chao, Ph.D.
Company Executives of CeriBell Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.10M
-0.26%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Ms. Erica J. Rogers
Ms. Erica J. Rogers
Director
Director
--
--
Brian Johnston
Brian Johnston
Investor Relations
Investor Relations
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+0.32%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.10M
-0.26%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
484.18K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
88.68K
-0.77%
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
52.06K
-41.11%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
+103.09%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
By BusinessUSD
Name
Revenue
Proportion
EEG recorders and EEG headbands, point in time
15.92M
75.11%
EEG portal and Clarity subscriptions, over time
5.28M
24.89%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
EEG recorders and EEG headbands, point in time
15.92M
75.11%
EEG portal and Clarity subscriptions, over time
5.28M
24.89%
Shareholding Stats
Updated: Mon, Sep 8
Updated: Mon, Sep 8
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
Other
56.52%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.79%
TPG Capital, L.P.
10.82%
Longitude Capital Management Co., LLC
6.75%
Ally Bridge Group (HK) Limited
6.66%
Global Value Investment Portfolio Management Pte. Ltd.
6.46%
Other
56.52%
Shareholder Types
Shareholders
Proportion
Investment Advisor
41.55%
Investment Advisor/Hedge Fund
18.75%
Private Equity
10.82%
Individual Investor
10.66%
Venture Capital
9.21%
Hedge Fund
2.82%
Research Firm
0.96%
Pension Fund
0.36%
Bank and Trust
0.20%
Other
4.67%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
179
30.96M
84.45%
+3.45M
2025Q2
162
33.13M
90.36%
+3.75M
2025Q1
157
34.07M
94.45%
+6.99M
2024Q4
111
32.79M
91.42%
+9.94M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.69M
12.79%
-62.59K
-1.32%
Jun 30, 2025
TPG Capital, L.P.
3.97M
10.82%
--
--
Jun 30, 2025
Longitude Capital Management Co., LLC
2.48M
6.75%
+2.48M
--
Oct 16, 2024
Ally Bridge Group (HK) Limited
2.44M
6.66%
+265.06K
+12.18%
Jun 30, 2025
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.46%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
6.02%
--
--
Jun 30, 2025
Parvizi (Josef)
2.09M
5.7%
+6.62K
+0.32%
Apr 11, 2025
BlackRock Institutional Trust Company, N.A.
1.37M
3.74%
+587.42K
+75.05%
Jun 30, 2025
The Vanguard Group, Inc.
1.33M
3.61%
+631.24K
+90.98%
Jun 30, 2025
Chao (Xingjuan)
1.10M
3%
-2.89K
-0.26%
Aug 25, 2025
View more
Related ETFs
Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
iShares Neuroscience and Healthcare ETF
0.52%
Hypatia Women CEO ETF
0.42%
Global X HealthTech ETF
0.28%
Fidelity Fundamental Small-Mid Cap ETF
0.1%
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Growth ETF
0.02%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
View more
iShares Neuroscience and Healthcare ETF
Proportion0.52%
Hypatia Women CEO ETF
Proportion0.42%
Global X HealthTech ETF
Proportion0.28%
Fidelity Fundamental Small-Mid Cap ETF
Proportion0.1%
iShares Micro-Cap ETF
Proportion0.06%
iShares Russell 2000 Growth ETF
Proportion0.02%
ProShares Hedge Replication ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
